Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-18

Clinical Trial Update: Early Norepinephrine in Trauma Patients With Hemorrhagic Shock [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 1/2 study of early norepinephrine use in trauma patients with hemorrhagic shock. The trial is currently enrolling by i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NOREPINEPHRINE (NOREPINEPHRINE BITARTRATE)

Snippet

Sponsor: Visarat Palitnonkiat | Conditions: Trauma, Multiple | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION